Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro.
Invest New Drugs
; 40(3): 478-486, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-34985593
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radiation-Sensitizing Agents
/
Head and Neck Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Invest New Drugs
Year:
2022
Document type:
Article
Affiliation country:
Austria
Country of publication:
United States